Exercise: friend or foe in adult congenital heart disease?

Abstract:

:Exercise training is beneficial in healthy adults as well as patients with acquired cardiovascular disease such as coronary artery disease and heart failure. While a reduced exercise capacity is common in adults with congenital heart disease, it is not clear if these patients stand to benefit from exercise training or if it could be potentially detrimental. International recommendations encourage regular exercise in these patients but the evidence base is limited. Data from cardiopulmonary exercise testing suggest a relatively low risk of adverse events during exercise in adults with congenital heart disease. This is also supported by studies investigating the mode of death in this patient group, reporting that only a minority of patients die during exercise. Regarding the benefits of exercise training in adults with congenital heart disease only a few studies with relatively small sample sizes are available pointing to beneficial effects in selected patients. Encouragingly, in none of these short-term studies were detrimental effects observed. Therefore, adult congenital heart disease patients should not be categorically discouraged from physical activity or from participating in non-competitive sports. However, individual exercise prescriptions should be based on a comprehensive assessment of the underlying cardiac condition, possible sequelae, cardiac function, arrhythmias, pulmonary hypertension, and aortic dimensions. Furthermore, the intensity of exercise should be adapted to individual exercise capacity.

journal_name

Curr Cardiol Rep

authors

Tutarel O,Gabriel H,Diller GP

doi

10.1007/s11886-013-0416-9

subject

Has Abstract

pub_date

2013-11-01 00:00:00

pages

416

issue

11

eissn

1523-3782

issn

1534-3170

journal_volume

15

pub_type

杂志文章,评审
  • Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

    abstract::The assessment of myocardial viability may be an important component of the evaluation of patients with coronary artery disease and left ventricular dysfunction. The primary goal of viability assessment in such patients is to guide therapeutic decisions by determining which patients would most likely benefit from reva...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-011-0242-x

    authors: Arrighi JA,Dilsizian V

    更新日期:2012-04-01 00:00:00

  • Renovascular hypertension in 2007: where are we now?

    abstract::Hypertension in patients with renovascular disease poses a major clinical challenge. Renal arterial disease accelerates hypertension by activation of multiple pressor systems. Although younger individuals with fibromuscular lesions often respond well to angioplasty with minor associated risks, care must be taken in ca...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/BF02938389

    authors: Textor SC

    更新日期:2007-11-01 00:00:00

  • GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: new trial and registry data.

    abstract::Primary percutaneous coronary intervention (PCI) with adjunctive glycoprotein (GP) IIb/IIIa receptor inhibitor therapy administered in the cardiac catheterization laboratory is the optimal reperfusion strategy for patients with ST-elevation myocardial infarction. Most available data regarding these agents are from tri...

    journal_title:Current cardiology reports

    pub_type: 杂志文章

    doi:10.1007/s11886-008-0066-5

    authors: Tamhane UU,Gurm HS

    更新日期:2008-09-01 00:00:00

  • Correction to: Review of Transthyretin Silencers, Stabilizers, and Fibril Removal Agents in the Treatment of Transthyretin Cardiac Amyloid.

    abstract::On page 2 of the original publication, in the section on TTR Silencers dosing of patisiran in the APOLLO study was stated as being given every 3 months; this is inaccurate as patisiran was dosed every 3 weeks in the APOLLO study. ...

    journal_title:Current cardiology reports

    pub_type: 已发布勘误

    doi:10.1007/s11886-020-01426-7

    authors: Hough A,Wearden J,de Almeida K,Kaiser S

    更新日期:2020-09-28 00:00:00

  • Cardiac Computed Tomography (CT) Evaluation of Valvular Heart Disease in Transcatheter Interventions.

    abstract:PURPOSE OF REVIEW:To establish the actual role of CT in the growing field of transcatheter valve interventions (THV). RECENT FINDINGS:The development of empirical CT measurements, which are linked with outcomes. CT is a reliable technique for assessing risk and planning transcatheter valve interventions for mitral and...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-019-1241-6

    authors: Godoy M,Mugharbil A,Anastasius M,Leipsic J

    更新日期:2019-11-25 00:00:00

  • Noninvasive assessment of coronary artery disease in women: What's next?

    abstract::Significant progress in research has been made in the areas of sex-specific aspects of cardiovascular disease. Despite these advances, coronary artery disease (CAD) is the leading cause of death of women in the Western world. Over the past decade, the focused research on women at risk for ischemic heart disease has he...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-010-0084-y

    authors: Phillips LM,Mieres JH

    更新日期:2010-03-01 00:00:00

  • Antiarrhythmic drugs 2013: state of the art.

    abstract::Antiarrhythmic drugs are widely used, but are of modest efficacy and have important side effects. However, even with the advance of catheter ablation for atrial fibrillation and ventricular tachycardia, antiarrhythmic drugs remain an important tool for treating arrhythmias. Antiarrhythmic drug development has remained...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-013-0410-2

    authors: Kumar K,Zimetbaum PJ

    更新日期:2013-10-01 00:00:00

  • Large-Scale Genomic Biobanks and Cardiovascular Disease.

    abstract:PURPOSE OF REVIEW:Cardiovascular disease is a leading cause of morbidity and mortality worldwide and is the focus of extensive biomedical research. Large genetic consortia combining data from many traditional prospective cohort and ascertained case-control study designs have facilitated the discovery of genetic associa...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-0969-8

    authors: Small AM,O'Donnell CJ,Damrauer SM

    更新日期:2018-03-08 00:00:00

  • Routine Angiographic Follow-Up After Coronary Artery Disease Revascularization: Is Seeing Believing?

    abstract:PURPOSE OF THE REVIEW:Coronary artery disease is a major cause of mortality and morbidity in the world, and PCI and CABG account for over a million procedures performed annually in the USA. The goal of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is to achieve complete revasculariz...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-0957-z

    authors: Agrawal H,Teleb M,Lahsaei S,Carbajal L,Montanez R,Carrozza JP Jr

    更新日期:2018-03-06 00:00:00

  • Lipid Screening, Action, and Follow-up in Children and Adolescents.

    abstract:PURPOSE OF REVIEW:To create awareness for the devastating influence of high cholesterol in familial hypercholesterolaemia (FH) on vessel walls. Persons with high LDL-C and a known mutation associated with FH have a 22-fold increase in CVD compared with those with a normal LDL-C and no genetic mutation. If the awareness...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-1014-7

    authors: Wiegman A

    更新日期:2018-08-09 00:00:00

  • Resistance to antiplatelet therapy.

    abstract::Cardiovascular mortality continues to be high and events continue to occur in patients taking antiplatelet medications. Aspirin and clopidogrel have become integral parts of management in patients with coronary artery disease and after percutaneous angioplasty. However, the platelet responses to aspirin and clopidogre...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-005-0044-0

    authors: Guthikonda S,Lev EI,Kleiman NS

    更新日期:2005-07-01 00:00:00

  • Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.

    abstract::Controlled clinical trials, performed in more than 13,000 patients, have consistently shown the beneficial effects of long-term beta-blocker therapy in patients with chronic heart failure. However, it is not clear whether this is a class effect or if it is specific only for some agents. Beneficial effects on the progn...

    journal_title:Current cardiology reports

    pub_type: 杂志文章

    doi:10.1007/s11886-000-0076-4

    authors: Metra M,Nodari S,Boldi E,Dei Cas L

    更新日期:2000-05-01 00:00:00

  • Shock to the Heart: Psychosocial Implications and Applications of Sudden Cardiac Death in the Young.

    abstract:PURPOSE OF REVIEW:Although rare, sudden cardiac death (SCD) in the young is a tragic event, having a dramatic impact upon all involved. The psychosocial burden associated with SCD can leave friends, families, and entire communities bereft. With only limited evidence to describe the volatile emotional reactions associat...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-020-01419-6

    authors: Grubic N,Puskas J,Phelan D,Fournier A,Martin LJ,Johri AM

    更新日期:2020-10-10 00:00:00

  • Hypertension in the developing world: a consequence of progress.

    abstract::Hypertension is one of the leading causes of death and disability in developing countries. The increasing burden of hypertension in these countries has been attributed to several indicators of economic progress such as increased life expectancy, urbanization and its attendant lifestyle changes, and the overall epidemi...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-006-0096-9

    authors: Reddy KS,Naik N,Prabhakaran D

    更新日期:2006-11-01 00:00:00

  • Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

    abstract::While pulmonary arterial hypertension is a disease primarily affecting the pulmonary vasculature, the right ventricle plays an integral part in the disease process. Although widely used, two-dimensional echocardiography is limited in visualizing the right ventricle and, therefore, assessment of its structure and funct...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-012-0253-2

    authors: Freed BH,Patel AR,Lang RM

    更新日期:2012-06-01 00:00:00

  • Percutaneous Endovascular Aortic Aneurysm Repair for Abdominal Aortic Aneurysm.

    abstract:PURPOSE OF REVIEW:This review discusses the benefits of a completely percutaneous approach to endovascular aortic aneurysm repair (EVAR), and provides an outline as to how this is performed by a multidisciplinary team of cardiologists and cardiovascular surgeons at a quaternary care community hospital. RECENT FINDINGS...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-1023-6

    authors: Huff CM,Silver MJ,Ansel GM

    更新日期:2018-07-26 00:00:00

  • Recent role of imaging in the diagnosis of pericardial disease.

    abstract::Noninvasive cardiac imaging techniques have made a striking impact on the evaluation and management of pericardial disorders. Two-dimensional and Doppler echocardiography are the methods of choice in the evaluation of pericardial effusion and cardiac tamponade. Magnetic resonance imaging, computed tomography, and tran...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-002-0124-3

    authors: Karia DH,Xing YQ,Kuvin JT,Nesser HJ,Pandian NG

    更新日期:2002-01-01 00:00:00

  • The Role of Manual Aspiration Thrombectomy in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI.

    abstract::In STEMI, primary PCI restores macrovascular coronary blood flow effectively but microvascular perfusion remains a challenge. Thrombus has the potential to embolize to the microvasculature limiting effective coronary blood flow. Thrombus burden is associated with a higher mortality and manual aspiration thrombectomy h...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-016-0707-z

    authors: Alak A,Jolly SS

    更新日期:2016-03-01 00:00:00

  • Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.

    abstract:PURPOSE OF REVIEW:The aim of the present manuscript is to review the latest advancements of radionuclide molecular imaging in the diagnosis and prognosis of individuals with cardiac amyloidosis. RECENT FINDINGS:99mTechnetium labeled bone tracer scintigraphy had been known to image cardiac amyloidosis, since the 1980s;...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0868-4

    authors: Bravo PE,Dorbala S

    更新日期:2017-07-01 00:00:00

  • White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty.

    abstract:PURPOSE OF REVIEW:This review aims to clarify the cardiovascular risk of white coat hypertension (WCH). RECENT FINDINGS:Cardiovascular risk of WCH has been evaluated in multiple meta-analyses and population-based studies. International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outc...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-0964-0

    authors: Abolbashari M

    更新日期:2018-03-08 00:00:00

  • Vascular Imaging Before Transcatheter Aortic Valve Replacement (TAVR): Why and How?

    abstract::Transcatheter aortic valve replacement (TAVR) has become an alternative to surgical intervention for symptomatic or severe aortic valve stenosis in patients with high surgical risk. Successful TAVR requires a multimodality imaging approach for appropriate patient selection and prosthesis sizing. Here, we describe indi...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-015-0694-5

    authors: Caruso D,Rosenberg RD,De Cecco CN,Mangold S,Wichmann JL,Varga-Szemes A,Steinberg DH,Laghi A,Schoepf UJ

    更新日期:2016-02-01 00:00:00

  • Antegrade, retrograde, and combination strategies for chronic total occlusions.

    abstract::Chronic total occlusion (CTO) represents one of the most challenging lesion subsets faced by the interventional cardiologist. CTO is a common problem, being present in more than 30% of patients undergoing coronary angiography. Over the past 10 years, the success rate of recanalization has increased from approximately ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-010-0131-8

    authors: Genereux P,Dangas G

    更新日期:2010-09-01 00:00:00

  • Adjuvant Antithrombotic Therapy in TAVR.

    abstract:PURPOSE OF REVIEW:Transcatheter aortic valve replacement (TAVR) has developed into an important alternative to surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis (AS). Adjuvant antithrombotic therapies are commonly used during and after TAVR to decrease the risk of valve thrombosis and th...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0850-1

    authors: O'Malley RG,Mahaffey KW,Fearon WF

    更新日期:2017-05-01 00:00:00

  • Ebstein's Anomaly of the Tricuspid Valve: an Overview of Pathology and Management.

    abstract:PURPOSE OF REVIEW:Ebstein's anomaly (EA) is a rare, but complex form of congenital heart disease consisting of a right ventricular myopathy and morphologic tricuspid valve disease leading to a high incidence of right ventricular dysfunction and arrhythmias. This review offers an updated overview of the current understa...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-020-01412-z

    authors: Possner M,Gensini FJ,Mauchley DC,Krieger EV,Steinberg ZL

    更新日期:2020-10-09 00:00:00

  • Beta-adrenergic blocking drugs as antifibrillatory agents.

    abstract::Beta-Adrenergic blockade is associated with a significant reduction in mortality in most patients with structural heart disease. Clinical trial data involving patients after myocardial infarction or with congestive heart failure demonstrate that a reduction in sudden death accounts for much of the observed mortality r...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-002-0043-3

    authors: Reiter MJ

    更新日期:2002-09-01 00:00:00

  • Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights.

    abstract:PURPOSE OF REVIEW:The cardiovascular (CV) risk related to lipid disorders is well established and is based on a robust body of evidence from well-designed randomized clinical trials, as well as prospective observational studies. In the last two decades, significant advances have been made in understanding the genetic b...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-019-1161-5

    authors: Stein R,Ferrari F,Scolari F

    更新日期:2019-06-21 00:00:00

  • Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist.

    abstract:PURPOSE OF REVIEW:Results from cardiovascular (CV) outcome trials have revealed important insights into the CV safety and efficacy of glucose-lowering agents, including dipeptidyl peptidase-4 inhibitors (DPP-4i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). RECENT FINDINGS:Among patients with T2DM, DPP-4i h...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-020-01355-5

    authors: Patel KV,Sarraju A,Neeland IJ,McGuire DK

    更新日期:2020-08-08 00:00:00

  • Deep venous thrombosis prophylaxis in patients with heart disease.

    abstract::Therapy to prevent deep venous thrombosis (DVT) and pulmonary embolism remains essential for inpatients, despite short periods of bedrest and hospitalization. Although most available data pertain to surgical patients, subgroups of medical patients are at moderate, high, and very high risk for DVT. These include patien...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-001-0011-3

    authors: Shively BK

    更新日期:2001-01-01 00:00:00

  • Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia.

    abstract:PURPOSE OF REVIEW:Assessing the cardiovascular risk associated with hypertriglyceridemia can be challenging due to frequent confounding conditions such as hypertension, diabetes mellitus, and hyperlipidemia. We sought to quantify this risk by examining several meta-analyses as well as subgroup analyses of previously pu...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-1013-8

    authors: Evans MC,Stalam T,Miller M

    更新日期:2018-07-10 00:00:00

  • Left ventricular assist devices and other devices for end-stage heart failure: utility of echocardiography.

    abstract::The burgeoning ranks of patients with heart failure, the limited number of organs available for heart transplant, and technological improvements have made ventricular assist devices (VADs) important therapeutic options for patients with acute and chronic cardiac decompensation. The increased use of VADs is paralleled ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-010-0102-0

    authors: Kirkpatrick JN,Wiegers SE,Lang RM

    更新日期:2010-05-01 00:00:00